Showing 1,341 - 1,360 results of 99,633 for search '(( 5 ((ppm decrease) OR (a decrease)) ) OR ( 5 ((nm decrease) OR (nn decrease)) ))', query time: 1.15s Refine Results
  1. 1341
  2. 1342
  3. 1343
  4. 1344
  5. 1345
  6. 1346

    A set of microphotographs and a graph documenting inhibition of neutrophil migration towards 10 µM CuSO<sub>4</sub> exposed hair cells resulting from co-treatment of 5 dpf Tg(MPX:G... by Natalia Kasica-Jarosz (5328554)

    Published 2018
    “…The presented values refer to the average number of neutrophils in each group. 100 nM PACAP-38 treatment resulted in a significant, over two-fold decrease in the number of the neutrophils found singly in the area defined by notochord borders and those associated with neuromasts as compared to that determined in the 10 µM CuSO<sub>4</sub>-exposed group (one-way ANOVA, Kruskal–Wallis test with Dunn’s post-test, GraphPad Prism 5, <i>p</i> < 0.001). …”
  7. 1347
  8. 1348
  9. 1349
  10. 1350
  11. 1351
  12. 1352
  13. 1353
  14. 1354
  15. 1355
  16. 1356
  17. 1357

    Changes in the normalized volume <i>v</i> = V/V<sub>0</sub> of HEK293 cells in response to sequential application of sucrose and <i>myo</i>-inositol solutions of the same osmolalit... by Joseph Andronic (700242)

    Published 2015
    “…<p>The cells were bathed initially (<i>time</i> < ∼30 s) in isotonic growth medium (300 mOsm) and then exposed to a 100-mOsm sucrose solution. The strongly hypotonic sucrose solution (<i>filled symbols</i>) caused fast cell swelling to a transient maximum volume <i>v</i><sub>max</sub> of ∼1.6 within the first 2–3 min. …”
  18. 1358

    The prolyl 4-hydroxylase inhibitor GSK360A decreases post-stroke brain injury and sensory, motor, and cognitive behavioral deficits - Fig 6 by Jin Zhou (90734)

    Published 2017
    “…<p>The effects of GSK360A on <b>(A)</b> mNSS, <b>(B)</b> beam balance, <b>(C)</b> foot fault and <b>(D)</b> hind limb performance at 5 hours, 1 day, 1 week and 3 weeks after stroke. …”
  19. 1359
  20. 1360

    The novel <i>carboxylesterase 1</i> variant c.662A>G may decrease the bioactivation of oseltamivir in humans by Jaeseong Oh (3947381)

    Published 2017
    “…A novel <i>CES1</i> c.662A>G single nucleotide polymorphism (SNP) was predicted to decrease CES1 enzymatic activity in an <i>in silico</i> analysis. …”